Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Jensen · SciRah

Researcher profile · Semantic Scholar

B. Jensen

Share profile

B. Jensen — researcher profile on SciRah

h-index: 36
Works: 163
Citations: 8,180

Most-cited papers

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
T. André, K. Shiu, T. W. Kim, B. Jensen +17 more
2020New England Journal of Medicine2,240 citations Open access
Semantic Scholar
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
L. Diaz, K. Shiu, Tae-Won Kim, B. Jensen +15 more
2022The Lancet Oncology684 citations Open access
Semantic Scholar
MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
N. Schultz, C. Dehlendorff, B. Jensen, J. Bjerregaard +8 more
2013Journal of the American Medical Association (JAMA)446 citations Open access
Semantic Scholar
Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study.
T. André, K. Shiu, T. W. Kim, B. Jensen +16 more
2020Journal of Clinical Oncology181 citations
Semantic Scholar
Pembrolizumab Versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase 3 KEYNOTE-177 study.
T. André, K. Shiu, T. Kim, B. Jensen +15 more
2024Annals of Oncology161 citations Open access
Semantic Scholar
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
T. André, M. Amonkar, J. Norquist, K. Shiu +16 more
2021The Lancet Oncology137 citations Open access
Semantic Scholar
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)
I. Chen, J. Johansen, S. Theile, J. Hjaltelin +14 more
2022Journal of Clinical Oncology92 citations Open access
Semantic Scholar
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
K. Spindler, A. Boysen, Niels Pallisgård, J. Johansen +8 more
2017The Oncologist80 citations Open access
Semantic Scholar
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab
K. Skougaard, D. Nielsen, B. Jensen, H. Hendel
2013Journal of Nuclear Medicine80 citations Open access
Semantic Scholar
A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.
D. Nielsen, J. Palshof, F. Larsen, B. Jensen +1 more
2014Cancer Treatment Reviews78 citations
Semantic Scholar
miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan
J. Schou, S. Rossi, B. Jensen, D. Nielsen +7 more
2014PLoS ONE78 citations Open access
Semantic Scholar
Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer
J. Schou, F. Larsen, B. Sørensen, R. Abrantes +5 more
2017Annals of Oncology65 citations Open access
Semantic Scholar
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer
I. Chen, N. Willumsen, C. Dehlendorff, A. Johansen +10 more
2020International Journal of Cancer53 citations Open access
Semantic Scholar
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy.
K. Spindler, N. Pallisgaard, A. Appelt, R. Andersen +8 more
2015European Journal of Cancer52 citations
Semantic Scholar
Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC).
T. André, K. Shiu, T. W. Kim, B. Jensen +16 more
202149 citations
Semantic Scholar
KEYNOTE-177: Phase III randomized study of pembrolizumab versus chemotherapy for microsatellite instability-high advanced colorectal cancer.
K. Shiu, T. André, T. W. Kim, B. Jensen +16 more
202149 citations
Semantic Scholar
The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer
J. Johansen, D. Calatayud, V. Albieri, N. Schultz +11 more
2016International Journal of Cancer48 citations Open access
Semantic Scholar
Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
Mogens K. Boisen, C. Dehlendorff, D. Linnemann, B. Nielsen +13 more
2014PLoS ONE44 citations Open access
Semantic Scholar
A systematic review of observational studies of trifluridine/tipiracil (TAS-102) for metastatic colorectal cancer
S. Andersen, I. Andersen, B. Jensen, P. Pfeiffer +2 more
2019Acta oncologica41 citations Open access
Semantic Scholar
Improved survival with early adjuvant chemotherapy after colonic resection for stage III colonic cancer: A nationwide study
M. Klein, Najah Azaquoun, B. Jensen, I. Gögenur
2015Journal of Surgical Oncology36 citations
Semantic Scholar
Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
I. Chen, V. Raymond, J. Geis, E. Collisson +5 more
2017OncoTarget35 citations Open access
Semantic Scholar
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
E. Kalanxhi, S. Meltzer, J. Schou, F. Larsen +8 more
2018British Journal of Cancer33 citations Open access
Semantic Scholar
Risk factors for brain metastases in patients with metastatic colorectal cancer
T. D. Christensen, J. Palshof, F. Larsen, E. Høgdall +6 more
2016Acta oncologica32 citations Open access
Semantic Scholar
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer
T. D. Christensen, J. Palshof, F. Larsen, T. Poulsen +5 more
2018Acta oncologica31 citations Open access
Semantic Scholar
MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability
M. Boisen, C. Dehlendorff, D. Linnemann, N. Schultz +3 more
2015BMC Cancer30 citations Open access
Semantic Scholar
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
O. Obazee, L. Archibugi, A. Andriulli, P. Souček +57 more
2019International Journal of Cancer29 citations Open access
Semantic Scholar
Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification
S. C. Lindgaard, Z. Sztupinszki, E. Maag, I. Chen +9 more
2021Clinical Cancer Research26 citations
Semantic Scholar
Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
Karin Bagni, I. Chen, A. Johansen, C. Dehlendorff +11 more
2020European Journal of Cancer Care26 citations Open access
Semantic Scholar
Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer.
L. S. Rasmussen, M. Yilmaz, U. Falkmer, L. Poulsen +14 more
2020European Journal of Cancer24 citations
Semantic Scholar
Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study.
L. S. Rasmussen, C. Fristrup, B. Jensen, P. Pfeiffer +14 more
2020European Journal of Cancer23 citations
Semantic Scholar
Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer
T. Yoshino, T. André, T. W. Kim, W. Yong +16 more
2022Cancer Science22 citations Open access
Semantic Scholar
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
K. Skougaard, H. Johannesen, D. Nielsen, J. Schou +3 more
2014Cancer Medicine21 citations Open access
Semantic Scholar
Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis
T. Dolin, I. Christensen, A. Johansen, H. Nielsen +7 more
2021Cancers19 citations Open access
Semantic Scholar
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
J. Palshof, E. Høgdall, T. Poulsen, D. Linnemann +7 more
2017BMC Cancer19 citations Open access
Semantic Scholar
LBA32 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study
K. Shiu, T. André, T. Kim, B. Jensen +15 more
2023Annals of Oncology18 citations Open access
Semantic Scholar
Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up
Hanna Abrahamsson, B. Jensen, Lise Lund Berven, D. Nielsen +5 more
2019International Journal of Cancer18 citations Open access
Semantic Scholar
Seeding after ultrasound-guided percutaneous biopsy of liver metastases in patients with colorectal or breast cancer
I. Chen, T. Lorentzen, D. Linnemann, C. Nolsøe +3 more
2016Acta oncologica17 citations Open access
Semantic Scholar
Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics
I. Kümler, P. G. Sørensen, J. Palshof, E. Høgdall +6 more
2018Cancer Chemotherapy and Pharmacology16 citations Open access
Semantic Scholar
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer
I. Chen, A. Johansen, C. Dehlendorff, B. Jensen +9 more
2019Cancer Epidemiology, Biomarkers and Prevention15 citations
Semantic Scholar
Identification of New Biomarkers in Patients with Pancreatic Cancer (BIOPAC): A Study Protocol of an Open Cohort Study
I. Chen, B. Jensen, S. Bojesen, A. Johansen +13 more
201915 citations
Semantic Scholar
Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High‐Risk Rectal Cancer
F. Larsen, A. Markussen, B. Jensen, A. Fromm +6 more
2017Clinical colorectal cancer14 citations
Semantic Scholar
The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancer.
M. H. Gramkow, C. S. Mosgaard, J. Schou, Ellen Hein Nordvig +10 more
2025Cancer Treatment and Research Communications13 citations Open access
Semantic Scholar
Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma - An external validation study.
S. D. Henriksen, B. Stubbe, P. Madsen, J. Johansen +6 more
2021Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]13 citations Open access
Semantic Scholar
Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer.
S. C. Lindgaard, C. Brinch, B. K. Jensen, H. Nørgaard +10 more
2019Breast13 citations
Semantic Scholar
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer.
A. Boysen, B. Sørensen, A. Lefèvre, R. Abrantes +13 more
2018Clinica chimica acta; international journal of clinical chemistry13 citations
Semantic Scholar
Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer
R. Eefsen, J. Larsen, L. Klarskov, Rahim Altaf +11 more
2023International Journal of Cancer11 citations Open access
Semantic Scholar
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
S. C. Lindgaard, E. Maag, Z. Sztupinszki, I. Chen +6 more
2022Cancers11 citations Open access
Semantic Scholar
Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status
B. Jensen, J. Schou, M. Yilmaz, H. Johannesen +7 more
2020International Journal of Cancer11 citations Open access
Semantic Scholar
ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer
J. Palshof, C. Cederbye, E. Høgdall, T. Poulsen +10 more
2020International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
396O Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
T. André, M. Amonkar, J. Norquist, K. Shiu +16 more
2020Annals of Oncology9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Johansen×19
Invite
J. Johansen — researcher profile on SciRah
P. Pfeiffer×18
Invite
P. Pfeiffer — researcher profile on SciRah
D. Nielsen×17
Invite
D. Nielsen — researcher profile on SciRah
M. Yilmaz×16
Invite
M. Yilmaz — researcher profile on SciRah

×11

Invite

S. Bojesen — researcher profile on SciRah

Invite

I. Chen — researcher profile on SciRah

E. Høgdall×11

Invite

E. Høgdall — researcher profile on SciRah

Invite

L. Jensen — researcher profile on SciRah

R. García-Carbonero×10

Invite

R. García-Carbonero — researcher profile on SciRah

Invite

F. Larsen — researcher profile on SciRah

Invite

J. Schou — researcher profile on SciRah

Invite

E. Élez — researcher profile on SciRah